Previous close | 9.80 |
Open | 9.78 |
Bid | 7.07 x 1800 |
Ask | 0.00 x 800 |
Day's range | 9.60 - 9.87 |
52-week range | 4.00 - 10.24 |
Volume | |
Avg. volume | 404,448 |
Market cap | 288.602M |
Beta (5Y monthly) | 0.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Neurocrine (NBIX) delivered earnings and revenue surprises of -9.89% and 4.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?